ALLIANCE PHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.85 GBX | +3.42% |
|
+13.60% | +8.27% |
| 09-02 | Alliance Pharma plc Announces Termination of Jeyan Heper as Director | CI |
| 08-12 | EXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRx | AN |
Main competitors
| 1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 8 | |||||||||
| 36 | |||||||||
| 11 | |||||||||
| 15 | |||||||||
| 35 | |||||||||
| 31 | |||||||||
| 13 | |||||||||
| 14 | |||||||||
| 9 | |||||||||
| 11 | |||||||||
| 2 | |||||||||
| 4 | |||||||||
| 6 | |||||||||
| - | 2 | ||||||||
| 3 | |||||||||
| 17 | |||||||||
| Average | 14 | ||||||||
| Weighted average by Cap. | 22 |
- Stock Market
- Equities
- APH Stock
- Sector Alliance Pharma plc
- Sector revisions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition